These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Basal-rate intravenous insulin infusion compared to conventional insulin treatment in patients with type II diabetes. A prospective crossover trial. Blackshear PJ; Roussell AM; Cohen AM; Nathan DM Diabetes Care; 1989; 12(7):455-63. PubMed ID: 2667926 [TBL] [Abstract][Full Text] [Related]
30. Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients. Saibene V; Melandri M; Brembilla L; Spotti D; Pozza G Acta Diabetol Lat; 1981; 18(1):45-50. PubMed ID: 7010856 [TBL] [Abstract][Full Text] [Related]
31. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion. Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730 [TBL] [Abstract][Full Text] [Related]
32. Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII. Scheen AJ; Henrivaux P; Jandrain B; Paolisso G; Lefèbvre PJ Diabetes Care; 1987; 10(5):567-72. PubMed ID: 3315513 [TBL] [Abstract][Full Text] [Related]
33. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229 [TBL] [Abstract][Full Text] [Related]
34. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies. Olsson PO Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929 [TBL] [Abstract][Full Text] [Related]
35. Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type I diabetic patients. Schiffrin A; Belmonte M Diabetes Care; 1981; 4(6):595-600. PubMed ID: 6751734 [TBL] [Abstract][Full Text] [Related]
36. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability]. Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045 [TBL] [Abstract][Full Text] [Related]
37. Early-morning hyperglycemia in diabetic individuals treated with continuous subcutaneous insulin infusion. Geffner ME; Frank HJ; Kaplan SA; Lippe BM; Levin SR Diabetes Care; 1983; 6(2):135-9. PubMed ID: 6682750 [TBL] [Abstract][Full Text] [Related]
38. [Nocturnal continuous subcutaneous insulin infusion--a therapeutic possibility in labile type I diabetes under exceptional conditions]. Bruns W; Steinborn F; Menzel R; Staritz B; Bibergeil H Z Gesamte Inn Med; 1990 Mar; 45(6):154-8. PubMed ID: 2197828 [TBL] [Abstract][Full Text] [Related]
39. Overnight interruption of wearing insulin pump: substitution dose and injection site of insulin. Helve E; Pelkonen R; Koivisto VA Diabetes Care; 1986; 9(6):565-9. PubMed ID: 3542449 [TBL] [Abstract][Full Text] [Related]
40. Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy. Koivisto VA; Tronier B Diabetes Care; 1983; 6(5):436-40. PubMed ID: 6400702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]